Loading provider…
Loading provider…
Pulmonary Disease Physician in Westminster, CA
NPI: 1043401698Primary Practice Location
Comprehensive Pulmonary Medical Group
14120 Beach Blvd, Westminster, CA
Primary Employer
Comprehensive Pulmonary Medical Group
dr-leonardo.com
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 203 | 1,158 |
| 2 | K1034Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 161 | 2,312 |
| 3 | G0008Administration of influenza virus vaccine | 53 | 53 |
| 4 | 94728Measurement of airway resistance by impulse oscillometry | 49 | 51 |
| 5 | 94375Test to measure rate of airflow | 49 | 51 |
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: J Med Case Rep
Publication Date: 2021-03-06
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Placebo, DRUG: Standard of care (SoC), DEVICE: Pre-filled Syringes (PFS), BIOLOGICAL: GSK3511294 (Depemokimab), BIOLOGICAL: Mepolizumab, BIOLOGICAL: Benralizumab
Lead Sponsor: Eli Lilly and Company
Collaborators: AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: LY3819253, DRUG: LY3832479, DRUG: LY3853113
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Insulin glargine (HOE901), DRUG: Background therapy, DRUG: Insulin glargine/Lixisenatide